1 / 34

Chest Wall, Lung, Mediastinum, & Pleura

Chest Wall, Lung, Mediastinum, & Pleura. May 11, 2010. Trachea. Tracheal Injury. Tracheal Stenosis Over-inflation of the cuff Ischemia, scarring, stricture Fistula development Incorrect placement of the tracheostomy through the first tracheal ring or the cricothyroid membrane

lani
Download Presentation

Chest Wall, Lung, Mediastinum, & Pleura

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chest Wall, Lung, Mediastinum, & Pleura May 11, 2010

  2. Trachea

  3. Tracheal Injury • Tracheal Stenosis • Over-inflation of the cuff • Ischemia, scarring, stricture • Fistula development • Incorrect placement of the tracheostomy through the first tracheal ring or the cricothyroid membrane • Use of a large tracheostomy tube • Stridor and dyspnea on exertion • Resection and primary anastomosis

  4. TracheoInnominate Artery Fistula • Causes • Too low placement of the tracheostomy (below the 4th ring) • Hyperinflation of the tracheal cuff • Typically occur 2 weeks after tracheostomy • Signs • Sentinel bleed • Heavy bleed – blow up cuff • Insert finger and press against manubrium • Oral intubation and emergent resection of fistlua

  5. TracheoEsophageal Fistula • Causes • ETT cuff compresses against NG tube • Signs • Gastric contents or tube feeds suctioned from airway • Gastric distention from positive pressure ventilation • Diagnosis • Bronchoscopy or EGD • Treatment • Wean off vent • Remove NG and place GT or JT • Operative repair involves resection and primary repair of tracheal pathology, repair of esophagus, and interposition muscle flap

  6. Tracheal Neoplasms • Rare • SCC or adenoid cystic carcinoma • Cough, dyspnea, hemoptysis, stridor, or symptoms of invasion of contiguous structures • 50% of patients have tracheal stenosis on Xray • 50% have stage IV dz at time of diagnosis • Overall 5-year survival is 40%, but falls to 15% for those with stage IV disease

  7. Surgical Approaches to the Thoracic Cavity • Posterior Thoracotomy – most common approach for pulmonary resections, esophageal procedures, posterior mediastinal access, and vertebral procedures • Patient in lateral decubitus – risk of injury to brachial plexus or axillary vascular structure • Anteriolateral Thoracotomy – trauma victims • Median sternotomy – cardiac procedures • VATS – improved pain and functional recovery • Improved ability to tolerate chemotherapy • Quicker return of respiratory function in elderly and COPD

  8. Post-operative Care • Chest Tube • Evacuation of air • Evacuation of blood/pleural fluid • Check the system regularly • Pain Control • Epidural at T6 with ropivicaine • Hypotension and urinary retention • Narcotics and Toradol • Aggressive Pulmonary Toilet

  9. Post-operative Complications • Air leak • Bronchopleural fistula • Diagnose by bronchoscopy • Continued chest tube mgmt • Operative closure with intercostal muscle flap • Bronchoscopic fibrin glue application (<4mm) • Concomitant empyema may require open drainage • Post-pneumonectomy pulmonary edema • Decreased lympnatic drainage • Mechanical ventilation & diuresis

  10. Lung • Solitary Pulmonary Nodule • A single, well-circumscribed, spherical lesion • ≤3 cm in diameter • Completely surrounded by normal aerated lung parenchyma • Detected incidentally on chest radiographs or CT scans • DDx – malignancy, hamartoma (10%), granulomatous dz (70%) • 20 to 40% likelihood of being malignant • 50% or higher in smokers • growth over time, • density of the lesion on CT • associated symptom • age, sex, cigarette smoking history, occupational history, • prevalence of endemic granulomatous disease

  11. Lung Cancer • Leading cause of cancer-related death (30%) • Second most common diagnosed cancer • Women – breast • Men – prostate

  12. Lung Cancer • Epidemiology • Leading risk factor – smoking (polycyclic aromatic hydrocarbons) • Secondhand smoke also increases risk • Environmental exposures - asbestos, arsenic, and chromium compounds • COPD • h/o tuberculosis

  13. Lung Cancer • Non-small cell carcinoma vs neuroendocrine tumors • NSCLC - large cell carcinoma, squamous cell carcinoma, adenocarcinoma, and BAC • Clinical behavior and treatment options are similar and thought of as a uniform group • Neuroendocrine - typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma

  14. Squamous Cell Carcinoma • 30 to 40% of lung cancers • Highly associated with cigarette smoking • Primarily located centrally and arises in the major bronchi • Typical symptoms are hemoptysis, bronchial obstruction with atelectasis, dyspnea, and pneumonia • Peripherally based SCC will develop in a tuberculosis scar or in the wall of a bronchiectatic cavity • Central necrosis is frequent and may lead to the radiographic findings of a cavity (air-fluid level) • May become infected & form an abscess

  15. Adenocarcinoma • Incidence has increased over the last several decades & now 25 to 40% of all lung cancers. • Most frequent histologic type found in women • Peripherally based tumor • Frequently discovered incidentally on routine chest radiographs • Symptoms of chest wall invasion or malignant pleural effusions • Composed of glands with or without mucin production and destruction of contiguous lung architecture

  16. Bronchoalveolar Carcinoma • Unusual (5% of all lung cancers) subtype of adenocarcinoma • Unique growth pattern • Rather than invading and destroying contiguous lung parenchyma, tumor cells multiply and fill the alveolar spaces • Because of their growth within alveoli, BAC tumor cells from one site can aerogenously seed other parts of the same lobe or lung, or the contralateral lung. • Three radiographic presentations: • a single nodule • multiple nodules (in single or multiple lobes) • diffuse form with an appearance mimicking that of a lobar pneumonia • Air bronchograms can be seen

  17. Large Cell Carcinoma • 10 to 20% of lung cancers and may be located centrally or peripherally • Often admixed with other cell types such as squamous cells or adenocarcinoma • May be confused with a large cell variant of neuroendocrine carcinoma, with immunohistochemical staining usually allowing diagnostic distinction between the two

  18. Neuroendocrine Carcinoma • Grade I NEC (classic or typical carcinoid) is a low-grade NEC • primarily in the central airways • primarily in younger patients. • classically presents with hemoptysis, with or without airway obstruction and pneumonia • Regional lymph node metastases are seen in 15% of patients but rarely spread systemically or cause death • Grade II NEC (atypical carcinoid) tumors with a degree of aggressive clinical behavior • linked to cigarette & peripherally located • Much higher malignant potential. • Lymph node metastases found in 30 to 50% of patients • At the time of diagnosis, 25% have remote metastases • Grade III NEC large cell–type tumors occur primarily in heavy smokers • Grade III NEC small cell type [small cell lung carcinoma (SCLC)] is the most malignant NEC and accounts for 25% of all lung cancers • Immunohistochemical stains distinguish from NSCLC • Leading producer of paraneoplastic syndromes

  19. Paraneoplastic Syndromes • Table 19-5 • Hypercalcemia (ectopic parathyroid hormone) • Cushing's syndrome • Syndrome of inappropriate secretion of antidiuretic hormone • Carcinoid syndrome • Gynecomastia • Hypercalcitoninemia • Elevated growth hormone level • Elevated levels of prolactin, follicle-stimulating hormone, luteinizing hormone • Hypoglycemia • Hyperthyroidism • Neuropathy

  20. Metastatic Symptoms • Lung cancer metastases occur most commonly to the CNS, vertebral bodies, bone, liver, adrenal glands, lungs, skin, and soft tissue • At diagnosis, 10% of patients have CNS metastases • another 10 to 15% will go on to develop CNS metastases after diagnosis. • Focal symptoms are most common and include headache, nausea and vomiting, seizures, hemiplegia, and speech difficulty • Most common cause of spinal cord compression • Invasion of an intervertebral foramen from a primary tumor contiguous with the spine • Direct extension of a vertebral metastasis. • Bony metastases, are identified in 25% - lytic and painful • Liver & adrenal metastases are typically asymptomatic and discovered by routine CT scan • Skin and soft tissue metastases occur in 8% of patients dying of lung cancer and generally present as painless subcutaneous or intramuscular masses

  21. Assessment of Primary Lung Cancer • History and directed questions regarding the presence or absence of pulmonary, nonpulmonary, thoracic, and paraneoplastic symptoms • Imaging • Nodes and invasion • Tissue diagnosis • Bronchoscopy or percutaneous biopsy • Thoracoscopy or rarely thoracotomy

  22. Staging • Mediastinal nodes • Stations 4 & 7 • CT scan & perc biopsy • PET • Bronchoscopy • Mediastinoscopy • EUS w FNA • Distant mets • PET-CT

  23. Staging System

  24. Chest Wall Tumors

  25. Mediastinal Tumors • Anterior (thymus) • Thymoma – always resect • 50% malignant • 50% have symptoms • 50% have myasthenia gravis • Thyroid cancer and goiter • T-cell lymphoma – treat with XRT and chemo • Teratoma – resection and chemo • Seminoma – resectiona and XRT • Parathyroid adenoma

  26. Mediastinal Tumors • Middle (heart, trachea, ascending aorta) • Bronchiogenic cyst – posterior to the carina - resect • Pericardial cyst – at right costophrenic angle – resect • Enteric cyst - resect • Lymphoma • Posterior (esophagus, descending aorta) • Enteric cysts • Neurogenic tumors – cause pain and neurologic deficit – resect – 10% have intraspinal involvement • Lymphoma

  27. Pleural Disease • Pleural effusion - any significant collection of fluid within the pleural space • Transudative vs exudative • Chylothorax – injury to thoracic duct

  28. Pleural Tumors • Malignant mesothelioma • 50% associated with asbestos exposure • Patients present with dyspnea and chest pain • Treatment options include supportive care only, surgical resection, and multimodality approaches • Fibrous Tumors • Unrelated to asbestos exposure or malignant mesothelioma • Single pedunculated mass arising from the visceral pleura • Found incidnetally • Benign or malignant • Symptoms such as cough, chest pain, and dyspnea occur in 30 to 40% of patients • Less common are fever, hypertrophic pulmonary osteoarthropathy, hemoptysis, and hypoglycemia • Cured by complete surgical resection

More Related